By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Pitavastatin

Pitavastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
5 Min Read
SHARE
3 min read|678 words

What is Pitavastatin?

Pitavastatin is a prescription medication that belongs to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease in adults. Pitavastatin is one of the newer statins, offering effective cholesterol management with a unique metabolism profile.

Uses

Primary hyperlipidemia and mixed dyslipidemia: Pitavastatin is prescribed to reduce elevated total cholesterol, LDL cholesterol, and triglyceride levels while increasing HDL (good) cholesterol in patients with various forms of high cholesterol.

Cardiovascular disease prevention: The medication helps reduce the risk of heart attack, stroke, and other cardiovascular events in patients with elevated cholesterol levels or existing risk factors.

Familial hypercholesterolemia: It can be used to treat inherited conditions that cause extremely high cholesterol levels, often in combination with dietary changes and other lifestyle modifications.

Submit Your Paper
GMJ_Submit_Banner

Secondary prevention: For patients who have already experienced cardiovascular events, pitavastatin may be prescribed as part of a comprehensive treatment plan to prevent future complications.

Diabetes-related dyslipidemia: The medication can help manage abnormal cholesterol patterns commonly seen in patients with type 2 diabetes.

How it works

Pitavastatin works by blocking an enzyme called HMG-CoA reductase, which is responsible for producing cholesterol in the liver. By inhibiting this enzyme, the medication reduces the liver’s ability to make cholesterol, forcing the body to remove cholesterol from the bloodstream to meet its needs. This dual action results in lower blood cholesterol levels and improved cardiovascular health outcomes.

Side effects

Common side effects:

  • Muscle pain or weakness
  • Joint pain
  • Headache
  • Nausea
  • Constipation
  • Diarrhea
  • Upper respiratory tract infections
  • Dizziness

Serious side effects:

  • Rhabdomyolysis (severe muscle breakdown that can cause kidney damage)
  • Liver problems, including elevated liver enzymes
  • Severe allergic reactions
  • New-onset diabetes or worsening of existing diabetes
  • Memory problems or confusion

Warnings and precautions

Muscle problems: Patients should be monitored for signs of muscle pain, tenderness, or weakness, especially when starting treatment or increasing doses. The risk increases with higher doses and certain drug combinations.

Liver function: Regular liver function tests may be recommended, particularly in patients with a history of liver disease or those consuming substantial amounts of alcohol.

Pregnancy and breastfeeding: Pitavastatin should not be used during pregnancy or while breastfeeding, as cholesterol is essential for fetal development and the drug may pass into breast milk.

Kidney impairment: Patients with severe kidney disease may require dose adjustments or alternative treatments, as reduced kidney function can affect drug clearance.

Age considerations: Elderly patients may be more susceptible to side effects and may require lower starting doses or more frequent monitoring.

Interactions

Cyclosporine: This immunosuppressive drug significantly increases pitavastatin levels, requiring dose adjustments or alternative treatments.

Rifampin: This antibiotic can reduce pitavastatin effectiveness by increasing its breakdown in the body.

Gemfibrozil: This cholesterol medication increases the risk of muscle problems when combined with pitavastatin.

Warfarin: Pitavastatin may enhance the blood-thinning effects of warfarin, requiring more frequent monitoring of clotting times.

Niacin: High doses of niacin combined with statins may increase the risk of muscle-related side effects.

Grapefruit juice: Unlike some other statins, pitavastatin has minimal interaction with grapefruit juice, but moderation is still recommended.

Antacids: Taking aluminum or magnesium-containing antacids may reduce pitavastatin absorption if taken simultaneously.

Colchicine: This gout medication may increase the risk of muscle problems when used with pitavastatin.

Check interactions with the GMJ Interaction Checker

Dosage

The typical starting dose for adults is 2 mg once daily, taken with or without food. Depending on individual response and cholesterol levels, the dose may be increased to a maximum of 4 mg daily. Some patients may start with 1 mg daily if they are at higher risk for side effects or have certain medical conditions. Dosage adjustments may be necessary for patients with kidney problems or those taking interacting medications. Healthcare providers will determine the appropriate dose based on individual patient factors, cholesterol targets, and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Pitavastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/pitavastatin/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Atorvastatin

By
GMJ News Desk
01/06/2026

Rosuvastatin

By
GMJ News Desk
01/06/2026

Pitavastatin

By
GMJ News Desk
01/06/2026

Simvastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up